Peter is Professor of Pathology in the Department of Molecular Medicine and Pathology, University of Auckland School of Medicine and a consulltant haematologist in the Department of Haematology, Auckland City Hospital. He is Director of the Blood Cancer NZ Research Unit and the lead for clinical research in the Department of Haematology, Auckland City Hospital . His clinical and research interests include leukaemia biology and genomics, and improving therapy and outcomes for patients with myeloid and other blood cancers.

Adam is a Senior Staff Specialist Haematologist at Liverpool Hospital in South Western Sydney (SWS) and a Conjoint Senior Lecturer with the University of New South Wales. He is the current President and NSW Councillor of the Haematology Society of Australia and New Zealand. At Liverpool Hospital, Adam leads the Myeloma and Plasma Cell Disorders Unit and serves as Deputy Director of the Transplant and Cellular Therapies Unit, where he is overseeing the development of the hospital’s standard-of-care CAR-T cell program for myeloma. Through the SWS Local Health District’s Haematology Clinical Research Unit, Adam has been Principal Investigator for numerous myeloma clinical trials, both industry-sponsored and collaborative. He is also a member of the Myeloma Working Party of the Australasian Leukaemia and Lymphoma Group and the Medical and Scientific Advisory Group (MSAG) of Myeloma Australia.